SPH3127 |
SPH3127 : Inhibitor of REN
Probe Summary
Selectivity
Potency
In Vivo
Control Compounds
Chemical Information
References
Vendors
Download
Probe Summary
| Targets | Biochemical/Biophysical Potency | Cellular Potency |
|---|---|---|
| REN |
|
|
Inhibitor
extracellular protein
Selectivity
Potency Cellular
In Vitro
REN
Mode of Action: Inhibitor
Structure-Activity-Relationship data available? No
DOI Reference: 10.1021/acs.jmedchem.2c00834
In Vivo Validations
Rat
Dose: 3 mg/Kg
Route of delivery:
Oral
Area Under the Curve::
124 ng*h/mL
Bioavailability:
24%
DOI Reference: 10.1021/acs.jmedchem.2c00834
Dose: 3 mg/Kg
Route of delivery:
Intravenous
Systemic clearance:
5692 mL/h/kg
Area Under the Curve::
528 ng*h/mL
DOI Reference: 10.1021/acs.jmedchem.2c00834
Monkey (Cynomolgus)
Dose: 3 mg/Kg
Route of delivery:
Oral
Area Under the Curve::
260 ng*h/mL
Bioavailability:
16%
DOI Reference: 10.1021/acs.jmedchem.2c00834
Dose: 3 mg/Kg
Route of delivery:
Intravenous
Systemic clearance:
1749 mL/h/kg
Area Under the Curve::
1725 ng*h/mL
DOI Reference: 10.1021/acs.jmedchem.2c00834
Negative Control Compounds
cpd 10
Notes: IC50 159 nM against rh-renin and 661 nM in the hPRA (plasma assay)
SMILES:
COCCCn1cc(CN(C2CC2)C(=O)[C@H]3CNCCO3)c4cccnc14
Chemical Information
| Molecular Formula | C22H32N6O4 |
| SMILEs | COC(=O)NCCCn1nc([C@@H](C)N(C(=O)[C@H]2CNCCO2)C2CC2)c2ccc(C)nc21 |
| InChI | InChI=1S/C22H32N6O4/c1-14-5-8-17-19(26-27(20(17)25-14)11-4-9-24-22(30)31-3)15(2)28(16-6-7-16)21(29)18-13-23-10-12-32-18/h5,8,15-16,18,23H,4,6-7,9-13H2,1-3H3,(H,24,30)/t15-,18-/m1/s1 |
| Molecular weight | 444.25 Da |
| AlogP | 0.0 |
| HBond acceptors | 10 |
| HBond donors | 2 |
| Atoms | 64 |
Vendors
Note: This is not an exhaustive list and does not indicate endorsement by the portal.